Prior to Braidwell, Alex was a Partner, Managing Director and the Co Portfolio Manager at Deerfield Management, from 2005 until 2021. He co-founded and previously served as chairman of The Institute for Life Changing Medicines, a nonprofit dedicated to developing medicines for people suffering from less common, life-threatening, diseases around the world. Alex previously served on the Board of the Biotechnology Innovation Organization, the Museum of Science, the Children’s Health Fund as Vice Chairman, New York Academy of Medicine, Discovery Labs, and Recovery Centers of America, the latter two of which he co-founded. Earlier in his career, he was a member of Merrill Lynch’s Global Equity Linked Products Group, as well as its Capital Markets team. He received a B.S. from the Massachusetts Institute of Technology and an M.S. from Johns Hopkins University.
Announcing New Members of Concordia’s Advisory Council
Concordia is pleased to announce the appointment of a distinguished group of global leaders to its Advisory Council. Representing a diverse range of sectors, geographies, and areas of expertise, these individuals bring
